19th Feb 2009 07:00
For immediate release 19 February 2009
ReGen Therapeutics Plc
Further Issue of Shares
Following yesterday's announcement of a placing to raise £65,155.02 before expenses, ReGen Therapeutics Plc ("ReGen" or the "Company"), (AIM: RGT) is pleased to announce that it has placed with existing and new investors a further 1,751,666 shares at 3p per share raising £52,550 before expenses.
The 1,751,666 new ordinary shares, which will represent 8.8 per cent of the enlarged issued share capital of the Company (19,880,550 ordinary shares) will rank pari passu in all respects with the existing ordinary shares in the Company.
Percy Lomax Chairman and Chief Executive commented:
'Following the affirmation of confidence in ReGen by its shareholders yesterday, positive market sentiment has encouraged further offers of investment at the same price. ReGen believes these extra funds will be useful in enhancing the Company's development programme and adding value for shareholders and has therefore proceeded with today's placing.'
Application has been made to the London Stock Exchange for the new ordinary shares to be admitted to trading on AIM and dealings in the new ordinary shares are expected to commence on or around 24 February 2009.
For further information, please contact:
Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel No 020 7628 3396
David Scott/Nick Bealer
Alexander David Securities Limited
Tel: 020 7448 9820
Related Shares:
TILS.L